HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,333-1,344 of 4,505
Behavioral study icon
CompletedNCT06284096

The Personal Recovery Based Psychoeducation For Schizophrenia

Official study title

Effect Of CHIME Based Group Psychoeducation On Personel Recovery In Individuals Diagnosed With Schizophrenia

This study has finished and is no longer accepting participants.

In Istanbul
SchizophreniaBehavioural studyAges 18–65
Countries
Türkiye
Sponsor
Istanbul University - Cerrahpasa
Device study icon
CompletedNCT07437365

Theta- and Alpha-Tuned Meditation for Negative Symptoms in Schizophrenia

Official study title

The Impact of Theta and Alpha Frequency-Tuned Meditation on Negative Symptoms in Schizophrenia: A Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Beirut
SchizophreniaDevice studyAges 18–65
Countries
Lebanon
Sponsor
Psychiatric Hospital of the Cross
Drug study icon
TerminatedNCT03351244

This Study Tests Whether BI 409306 Prevents people with Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

Official study title

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 28-week Treatment Period as Adjunctive Therapy to Antipsychotic Treatment for the Prevention of Relapse in Patients With Schizophrenia.

This study ended early.

Multiple locations, including Phoenix
SchizophreniaMedication studyAges 18–55
Countries
United States, France, Canada, + 4 others
Sponsor
Boehringer Ingelheim
Drug study icon
CompletedNCT03859973

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in people with Schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of BI 425809 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–50
Countries
United States, Australia, France, + 3 others
Sponsor
Boehringer Ingelheim

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.